FDA+ roundup: New draft guid­ance on ther­a­peu­tic equiv­a­lence; Cavaz­zoni talks ac­cel­er­at­ed ap­provals

The FDA on Wednes­day re­leased new draft guid­ance spelling out ex­act­ly how it con­ducts ther­a­peu­tic equiv­a­lence (TE) eval­u­a­tions for gener­ic and fol­low-on drugs.

The …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER